HLA-C and embryonal carcinoma: In an in vivo teleological perspective, the expression of NKG2D ligands and the lack of expression of HLA-C and -E by pluripotent stem cells would carry the benefit of prohibiting the development of germ-cell-derived embryonal carcinomas or tumors resulting from errors in embryonic implantation and development.